Related Experiment Video
Updated: Sep 14, 2026

In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
Published on: May 4, 2016
Effects of pyridoxine on serum protein expression in hepatoma-bearing rats
Abstract:
The effect of pyridoxine depletion on the expression of serum protein species in control and Morris hepatoma No. 7777-bearing rats was studied with polyacrylamide gel electrophoresis (PAGE). A group of 20 Buffalo female rats was fed ad libitum a complete diet lacking pyridoxine, whereas a similar group was fed the same diet with pyridoxine. After a 22-day feeding period, 12 animals from each group were inoculated with hepatoma No. 7777 cells in the thigh muscles of both hind legs and allowed to grow for 25 days. Sera were obtained from all animals by heart puncture under light ether anesthesia, and protein species were resolved by PAGE. Eight and four protein bands in the haptoglobin and postalbumin regions, respectively, were resolved from control rat serum, whereas sera from depleted animals had eight and three bands, respectively. Protein expression was facilitated by the presence of hepatomas. Ten and six protein bands were seen in the haptoglobin and postalbumin regions, respectively, upon PAGE of sera from control tumor-bearing rats. A positive synergistic effect between pyridoxine lack and tumor presence was also found. Twelve and five bands were resolved in the haptoglobin and postalbumin regions, respectively, when sera from pyridoxine-depleted tumor-bearing rats were electrophoresed. These results showed that vitamin B6, in addition to its well-known coenzymatic function, exercised a type of control over protein expression, which may be positive or negative depending on the nutritional and health status of the animal.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

